Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials for Cancer in United States

7241 results

Sort By:

Contrast-enhanced Spectral Mammography (CESM) Breast Cancer Screening

Study ID: NCT04904757
Start Date: 2019-09-19
End Date: 2023-06
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

210

Intervention / Treatment

Contrast-enhanced spectral mammography (CESM)

Sponsor

University of Virginia

Source: clinicaltrials.gov

Share:
Add to list

Concurrent WOKVAC Vaccination, Chemotherapy, and HER2-Targeted Monoclonal Antibody Therapy Before Surgery for the Treatment of Patients With Breast Cancer

Study ID: NCT04329065
Start Date: 2022-04-20
End Date: 2027-06-30
Study Type

Interventional

Study Phase

Phase2

No. of Participants

16

Intervention / Treatment

pUMVC3-IGFBP2-HER2-IGF1R Plasmid DNA Vaccine

Paclitaxel

Trastuzumab

Pertuzumab

Docetaxel

Carboplatin

Ultrasound Imaging

Biopsy Procedure

Biospecimen Collection

Sponsor

University of Washington

Source: clinicaltrials.gov

Share:
Add to list

A Phase 1/2, Open-label, Multicenter, FIH Study to Evaluate Safety, Tolerability, PK and Anti-tumor Activity of YH42946

Study ID: NCT06616766
Start Date: 2024-10-02
End Date: 2028-07-29
Study Type

Interventional

Study Phase

Phase2

No. of Participants

161

Intervention / Treatment

42946

Sponsor

Yuhan Corporation

Source: clinicaltrials.gov

Share:
Add to list

IlluminOss Photodynamic Bone Stabilization System for the Treatment of Impending and Actual Pelvis Fractures

Study ID: NCT04842266
Start Date: 2021-11-18
End Date: 2024-10-15
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

100

Intervention / Treatment

IlluminOss pelvic implant for oncologic indication

IlluminOss pelvic implant for geriatric trauma indication

Sponsor

Massachusetts General Hospital

Source: clinicaltrials.gov

Share:
Add to list

Phase 3 Study of PDS0101 and Pembrolizumab in HPV16+ Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma

Study ID: NCT06790966
Start Date: 2025-05-30
End Date: 2029-02
Study Type

Interventional

Study Phase

Phase3

No. of Participants

351

Intervention / Treatment

Combination Treatment of PDS0101 and Pembrolizumab

Pembrolizumab Monotherapy

Sponsor

PDS Biotechnology Corp.

Source: clinicaltrials.gov

Share:
Add to list

M-PART in Head and Neck Cancer Patients Treated With KeraStat Cream for Acute Radiation Dermatitis

Study ID: NCT06441266
Start Date: 2025-05-08
End Date: 2027-08
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

16

Intervention / Treatment

Kerastat cream

M-PART Assessments via MyCap

Clinical Assessments

Feedback phone interview

Sponsor

Wake Forest University Health Sciences

Source: clinicaltrials.gov

Share:
Add to list

Pembrysumab Plus Olaparib in LA-HNSCC

Study ID: NCT05366166
Start Date: 2022-09-02
End Date: 2026-10-31
Study Type

Interventional

Study Phase

Phase2

No. of Participants

45

Intervention / Treatment

Pembrolizumab

Flapberry

Cisplatin

IMRT (intensity modulated radiation therapy)

Sponsor

UNC Lineberger Comprehensive Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Multi-Parametric Quantitative MR Imaging in Evaluation of Brain Tumors

Study ID: NCT02956291
Start Date: 2017-02-15
End Date: 2025-12
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

84

Intervention / Treatment

Magnetic Resonance Fingerprinting

Sponsor

Case Comprehensive Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Clinical Trial of Approaches to Prostate Cancer Surgery

Study ID: NCT05155501
Start Date: 2023-05-15
End Date: 2026-12
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

600

Intervention / Treatment

Robot-assisted radical prostatectomy (RP)

Pelvic fascia-sparing robot-assisted radical prostatectomy (PFS-RP)

Sponsor

Weill Medical College of Cornell University

Source: clinicaltrials.gov

Share:
Add to list

Retinoblastoma Survivor Study: Assessment of General Health and Quality of Life

Study ID: NCT00639301
Start Date: 2008-03-11
End Date: 2026-03
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

1000

Intervention / Treatment

Questionnaires

Sponsor

Memorial Sloan Kettering Cancer Center

Source: clinicaltrials.gov

Share:
Add to list